Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial glycolytic enzymes and metabolic machinery in oral pathogens refers to the collective biochemical pathways and proteins used by cariogenic and periodontopathic bacteria, such as Streptococcus mutans and Porphyromonas gingivalis, to process carbohydrates and maintain cellular homeostasis in the oral cavity [1, 14]. The central component is the glycolytic pathway, which converts dietary sugars into organic acids (primarily lactic acid), a process known as acidogenesis that leads to tooth enamel demineralization and dental caries [14, 15]. Key enzymes in this machinery include enolase, which catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate, and various glucosyltransferases (GTFs) that synthesize extracellular polysaccharides (glucans) essential for biofilm formation and bacterial adherence [6, 12]. Additionally, the machinery includes transport systems like the phosphoenolpyruvate-dependent phosphotransferase system (PTS) and the F-type H+-ATPase, which regulates intracellular pH [10]. Therapeutic targeting of these enzymes, most notably through the use of fluoride and xylitol, aims to inhibit acid production and biofilm stability, thereby preventing oral diseases while ideally preserving the commensal microflora [8, 10]. Novel small molecules like #G43 and natural products like apigenin are also being explored to selectively disrupt the virulence factors of specific pathogens [2, 6, 15].
Inhibition of enolase (phosphopyruvate hydratase), inhibition of glucosyltransferases (GtfB, GtfC, GtfD), inhibition of F-type H+-ATPase, and disruption of the phosphoenolpyruvate-dependent phosphotransferase system (PTS) for sugar uptake.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial glycolytic enzymes and metabolic machinery in oral pathogens.